Mednet Logo
HomeNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How do you treat depression symptoms in patients with Parkinson's disease?

3
2 Answers

Mednet Member
Mednet Member
Neurology · Portland VA PADRECC

The management of PD-related depression can be a little complicated, but there are several proposed algorithms out there based on varying degrees of evidence. Personally, I like this reference (Pontone and Mills, PMID 33648830) as a place to start. It makes 3 key points: Distinguishing between PD an...

Is Migraine with Unilateral Motor Symptoms (MUMS) a diagnostic entity worth considering in patients with migraine and other associated symptoms?

1
2 Answers

Mednet Member
Mednet Member
Neurology · UPMC

I do not think so. It is not a part of the ICHD-3 criteria. If a patient with migraine disorder presents with weakness, it is possible that the weakness/motor symptoms are symptoms of migraine disorder. There is a diagnostic classification for such a patient already in the ICHD-3 criteria, which wou...

Do any subgroups of headache patients benefit more from neuromodulation devices compared to pharmacologic treatment?

1 Answers

Mednet Member
Mednet Member
Neurology · Brown Neurology

I think patients with episodic cluster headache benefit greatly from external vagus nerve stimulation (gammaCore) use. This device aborts cluster attacks and has a preventative action as well for future attacks during a cluster bout. It allows for more than 2 treatments per day if the patient is hav...

What treatment do you use for stroke prevention in cervical artery dissection?

3
2 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

Two prior RCTs (CADISS and TREAT-CAD) investigated this topic, each with distinct designs. The CADISS trial found no statistically significant difference in primary outcomes between antiplatelet and anticoagulation therapy for extra-cranial dissection. However, the TREAT-CAD trial failed to demon...

How do you approach evaluation of a patient referred for mononeuritis multiplex and +SSB?

2 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Step 1: A clinical syndrome of mononeuropathy multiplex always requires an EMG study. Is the primary mechanism of the MnM axonal or demyelinating? If it is demyelinating, there are only two possible diagnoses: multifocal CIDP (Lewis Sumner syndrome, which can occur in the context of Sjogren's syndro...

What is your approach to secondary stroke prevention in patients with atrial fibrillation and intracranial stenosis (>70%)?

8
6 Answers

Mednet Member
Mednet Member
Neurology · Harvard Medical School

The patient clearly needs to be on an anticoagulant for stroke prevention with atrial fibrillation and I would choose apixaban. If an antiplatelet is added to the apixaban, the risk of a major bleeding side effect is significantly increased. It is uncertain if apixaban is effective in reducing the r...

When should you seek hyperbaric oxygen therapy for patients with CRAO?

1
2 Answers

Mednet Member
Mednet Member
Neurology · Advocate Medical Group Neurology

I usually pursue hyperbaric oxygen therapy within the 24-hour window from symptom onset for CRAO. This can be performed following TNK if given. In reality, though, there are multiple barriers to achieving this, including: Few centers offer hyperbaric oxygen therapy Labor intensive Difficulty with i...

At what lab values (ferritin, TSAT%) would you offer IV iron therapy to patients with restless leg syndrome?

3
2 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

1. I am hopeful that practitioners will start understanding that ferritin alone is not enough to assess iron because of its acute phase reactivity. I like to order iron parameters after a 5-9 hour fast so the serum iron is not speciously elevated and get a ferritin and TSAT. If the ferritin is <30 a...

How do you utilize Diamox in patients with cerebral venous sinus thrombosis and vision symptoms who do not undergo thrombectomy/recanalization?

2
3 Answers

Mednet Member
Mednet Member
Neurology · The University of Iowa

Diamox (acetazolamide) is often used to treat papilledema with associated visual loss in cases of CVST. While there is a theoretical risk of dehydration from acetazolamide with potential worsening of the thrombosis, 1) acetazolamide is a weak diuretic and 2) the risk of blinding visual loss usually ...

How do you decide between the different oral longer acting levodopa medications?

1
2 Answers

Mednet Member
Mednet Member
Neurology · UC San Diego

The question would be, why are you changing, and what are you changing from? (i.e., are one of these your initial agent, a change due to Sinemet side effects, or a change because of motor fluctuations?) The current theory on dopamine replacement is "smoother is better," so the longer (and lower) you...